Top Markets
Coin of the day
Beijing Tiantan Biological Products Co., Ltd. Beijing Tiantan Biological Products Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd.

600161
Rang in Aktien #4525
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and... Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.
Aktienkurs
$1.81
Zuletzt synchronisiert: 2026-08-26
Marktkapitalisierung
$3.59B
Veränderung (1 Tag)
1.62%
Veränderung (1 Jahr)
-35.81%
Land
CN
Handel Beijing Tiantan Biological Products Co., Ltd. (600161)

Kategorie

Dividendenrendite-Verlauf für Beijing Tiantan Biological Products Co., Ltd. (600161)
Dividendenrendite (TTM) von Beijing Tiantan Biological Products Co., Ltd. (Aktienkürzel: 600161) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Beijing Tiantan Biological Products Co., Ltd. (600161) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH